179 related articles for article (PubMed ID: 16872820)
1. Improving outcome of allogeneic stem cell transplantation by immunomodulation of the early post-transplant environment.
Barrett J
Curr Opin Immunol; 2006 Oct; 18(5):592-8. PubMed ID: 16872820
[TBL] [Abstract][Full Text] [Related]
2. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
3. Expanded donor natural killer cell and IL-2, IL-15 treatment efficacy in allogeneic hematopoietic stem cell transplantation.
Chen G; Wu D; Wang Y; Cen J; Feng Y; Sun A; Tang X; Chang H; Zhu Z
Eur J Haematol; 2008 Sep; 81(3):226-35. PubMed ID: 18573173
[TBL] [Abstract][Full Text] [Related]
4. [Immunologic reconstitution after allogeneic stem cell transplant].
Lacerda JF
Acta Med Port; 2004; 17(6):471-80. PubMed ID: 16197859
[TBL] [Abstract][Full Text] [Related]
5. Selective elimination of alloreactivity from immunotherapeutic T cells by photodynamic cell purging and memory T-cell sorting.
Le NT; Chen BJ; Chao NJ
Cytotherapy; 2005; 7(2):126-33. PubMed ID: 16040391
[TBL] [Abstract][Full Text] [Related]
6. The history and future prospective of haplo-identical stem cell transplantation.
Handgretinger R; Lang P
Cytotherapy; 2008; 10(5):443-51. PubMed ID: 18615344
[TBL] [Abstract][Full Text] [Related]
7. Modulation of GvHD by suicide-gene transduced donor T lymphocytes: clinical applications in mismatched transplantation.
Ciceri F; Bonini C; Gallo-Stampino C; Bordignon C
Cytotherapy; 2005; 7(2):144-9. PubMed ID: 16040393
[TBL] [Abstract][Full Text] [Related]
8. Selective depletion strategies in allogeneic stem cell transplantation.
Mielke S; Solomon SR; Barrett AJ
Cytotherapy; 2005; 7(2):109-15. PubMed ID: 16040390
[TBL] [Abstract][Full Text] [Related]
9. Augmentation of post transplant immunity: antigen encounter at the time of hematopoietic stem cell transplantation enhances antigen-specific donor T-cell responses in the post transplant repertoire.
Mori S; Kocak U; Shaw JL; Mullen CA
Bone Marrow Transplant; 2005 Apr; 35(8):793-801. PubMed ID: 15750607
[TBL] [Abstract][Full Text] [Related]
10. Cytolytic pathways in haematopoietic stem-cell transplantation.
van den Brink MR; Burakoff SJ
Nat Rev Immunol; 2002 Apr; 2(4):273-81. PubMed ID: 12001998
[TBL] [Abstract][Full Text] [Related]
11. Improving immune reconstitution while preventing GvHD in allogeneic stem cell transplantation.
André-Schmutz I; Dal Cortivo L; Fischer A; Cavazzana-Calvo M
Cytotherapy; 2005; 7(2):102-8. PubMed ID: 16040389
[TBL] [Abstract][Full Text] [Related]
12. Current status of haploidentical stem cell transplantation.
Dey BR; Spitzer TR
Br J Haematol; 2006 Nov; 135(4):423-37. PubMed ID: 16984391
[TBL] [Abstract][Full Text] [Related]
13. Immunotherapy by allogeneic stem cell transplantation.
Ringdén O
Adv Cancer Res; 2007; 97():25-60. PubMed ID: 17419940
[TBL] [Abstract][Full Text] [Related]
14. Improving the ex vivo retroviral-mediated suicide-gene transfer process in T lymphocytes to preserve immune function.
Robinet E; Fehse B; Ebeling S; Sauce D; Ferrand C; Tiberghien P
Cytotherapy; 2005; 7(2):150-7. PubMed ID: 16040394
[TBL] [Abstract][Full Text] [Related]
15. Exploiting beneficial alloreactive T cells.
Barber LD; Madrigal JA
Vox Sang; 2006 Jul; 91(1):20-7. PubMed ID: 16756597
[TBL] [Abstract][Full Text] [Related]
16. Leukemia: cord blood for allogeneic stem cell transplantation.
Takahashi S
Curr Opin Oncol; 2007 Nov; 19(6):667-72. PubMed ID: 17906469
[TBL] [Abstract][Full Text] [Related]
17. A revision of Billingham's tenets: the central role of lymphocyte migration in acute graft-versus-host disease.
Sackstein R
Biol Blood Marrow Transplant; 2006 Jan; 12(1 Suppl 1):2-8. PubMed ID: 16399577
[TBL] [Abstract][Full Text] [Related]
18. The anti-tumor effect of allogeneic bone marrow/stem cell transplant without graft vs. host disease toxicity and without a matched donor requirement?
Har-Noy M; Slavin S
Med Hypotheses; 2008; 70(6):1186-92. PubMed ID: 18054441
[TBL] [Abstract][Full Text] [Related]
19. The influence of infection early after allogeneic stem cell transplantation on the risk of leukemic relapse and graft-versus-host disease.
Kim SY; Lee DG; Kim MS; Kim HJ; Lee S; Min CK
Am J Hematol; 2008 Oct; 83(10):784-8. PubMed ID: 18661492
[TBL] [Abstract][Full Text] [Related]
20. Rapid immune reconstitution after a reduced-intensity conditioning regimen and a CD3-depleted haploidentical stem cell graft for paediatric refractory haematological malignancies.
Chen X; Hale GA; Barfield R; Benaim E; Leung WH; Knowles J; Horwitz EM; Woodard P; Kasow K; Yusuf U; Behm FG; Hayden RT; Shurtleff SA; Turner V; Srivastava DK; Handgretinger R
Br J Haematol; 2006 Nov; 135(4):524-32. PubMed ID: 17010105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
